Beyond Innovation: Turning Ketamine and TMS Into Safe, Scalable Care Through Transition & Activation Planning

By: Donna Demerjian, Ph.D., LCSW

Innovative treatments such as ketamine therapy and Transcranial Magnetic Stimulation (TMS) are rapidly reshaping the behavioral health landscape. Driven by increasing demand and promising clinical outcomes, these therapies are expanding access for individuals who have not found relief through traditional approaches for conditions such as depression, anxiety, PTSD, substance use disorder, and chronic pain.

The data tells a compelling story:

  • TMS studies show response rates of approximately 50–60%, with remission rates around 30–35% for treatment-resistant depression.
  • Ketamine therapy has demonstrated rapid symptom relief—often within hours to days—with similar response rates of approximately 50–60%.

As adoption continues to grow, these therapies are becoming essential components of the modern behavioral health continuum. Across the United States, healthcare organizations are investing in dedicated interventional psychiatry programs and purpose-built environments to support this evolving model of care.

But innovation alone is not enough.

At Yellow Brick, we’ve seen firsthand that bringing advanced therapies into a healthcare setting requires more than clinical capability—it requires intentional, structured activation planning to ensure these services are delivered safely, compliantly, and sustainably from Day 1.

Why Innovation Needs Operational Readiness

Behavioral health environments are inherently complex, and interventional psychiatry services introduce additional layers of clinical, operational, and regulatory considerations.

Successfully launching TMS and ketamine programs requires alignment across three critical dimensions:

  • People – ensuring staff are trained, confident, and competent
  • Process – establishing clear, efficient, and safe workflows
  • Environment – designing spaces that support both therapeutic care and clinical safety

Yellow Brick’s Transition & Activation Planning model is built to align these elements—ensuring that innovation translates into high-quality patient care.

Our approach integrates interdisciplinary workflow planning, staff readiness, and regulatory compliance into a single, coordinated strategy that supports operational success from the start.

Designing Workflows That Support Advanced Therapies

Operational workflows are the backbone of any successful interventional psychiatry program. Without clearly defined processes, even the most advanced therapies can struggle to scale or deliver consistent outcomes.

A well-designed workflow for TMS and ketamine services should include:

  • Structured referral, screening, and medical clearance pathways to ensure appropriate patient selection
  • Defined inclusion and exclusion criteria, supported by clinical decision-making frameworks
  • Patient education and informed consent processes that set clear expectations and build trust
  • Day-of-treatment workflows that address check-in, monitoring, recovery, discharge, and follow-up
  • Emergency response protocols and escalation pathways to manage adverse events safely
  • Seamless coordination across psychiatry, nursing, pharmacy, and support services

At Yellow Brick, we facilitate interdisciplinary workflow planning sessions that bring together clinical and operational stakeholders to map, test, and validate these processes—ensuring alignment before patients ever enter the space.

Staff Readiness: Building Confidence Before Day One

Even the most thoughtfully designed workflows require a prepared workforce to execute them.

For interventional psychiatry programs, staff readiness must go beyond general orientation to include:

  • Competency-based training on treatment protocols and equipment, including TMS devices and infusion processes
  • Education on patient monitoring, side-effect management, and emergency response
  • Scenario-based training and simulation exercises to reinforce clinical decision-making
  • Dress Rehearsal events that test workflows in a real-world environment prior to go-live
  • Training grounded in trauma-informed and person-centered care

Our service methodology emphasizes experiential learning—ensuring that teams don’t just understand processes on paper, but can confidently execute them in practice. This focus on readiness is critical to reducing risk and improving both staff and patient experience at go-live.

Navigating Regulatory and Compliance Complexity

Interventional psychiatry programs must operate within a complex and evolving regulatory landscape.

Key considerations include:

  • Updating licensure and scope of services to reflect interventional psychiatry offerings
  • Aligning with federal and state regulations, recognizing that ketamine therapy requirements vary by state
  • Meeting CMS Conditions of Participation and The Joint Commission (TJC) standards
  • Establishing protocols for screening, contraindications, and adverse event response
  • Addressing DEA and medication management requirements
  • Implementing robust documentation, quality monitoring, and outcomes tracking

Regulatory readiness is not a one-time task—it is embedded throughout the transition process. Yellow Brick integrates compliance into every phase of planning, from early assessments through Day 1 activation and beyond, ensuring organizations are survey-ready while maintaining focus on patient safety.

From Innovation to Impact

The rise of TMS and ketamine therapy represents a meaningful shift in behavioral health care—offering new hope to patients who have not found success with traditional treatments.

It is the combination of strong operational planning, well-designed workflows, and a confident, prepared workforce that transforms new services into safe, scalable, and sustainable care models.

At Yellow Brick, we believe Transition & Activation Planning is the bridge between vision and reality—ensuring that innovative therapies are not only introduced successfully but thrive as part of a high-performing behavioral health system.